Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:10 AM
Ignite Modification Date:
2025-12-25 @ 12:10 AM
NCT ID:
NCT03248258
Eligibility Criteria:
Patient Criteria (Phase I,II,III):
Inclusion Criteria:
* 1\. Women with age ≥ 18
* 2\. Presence of Metastatic Breast Cancer or Early Stage Breast Cancer
* 3\. Patients may be receiving any line and type of therapy including both standard of care and clinical trials.
Exclusion Criteria:
* 1\. Patient who are not able to read and/or speak English
* 2\. Patients with a life expectancy less than 3 months
* 3\. Patients unable to provide informed consent
* 4\. Men
Patient Advocates (Phase III)
Inclusion criteria:
1\. Providers who are self-identified patient advocates working with breast cancer researchers
Exclusion criteria:
1. None
Sampling: We will conduct interviews with 10-20 patient advocates for phase 3 of this project.
Provider (navigator, nurse, physician) (Pjhase I, III)
Inclusion criteria:
2. Providers who have direct contact with breast cancer patients
Exclusion criteria:
2\. None
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03248258
Study Brief:
Protocol Section:
NCT03248258